Global pharmacogenomics market share forecast by region 2018 and 2028

Published by
Matej Mikulic,
Aug 8, 2022
North America's share of the global pharmacogenomics market in 2018 stood at some 51 percent. By 2028, this percentage is projected to decrease to under 49 percent. Pharmacogenomics is the science of how a patient's genes respond to certain drugs. It is becoming particularly important with the rise of precision medicine and personalized medicine.

Global pharmacogenomics market share in 2018 and a forecast for 2028, by region

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

In cooperation with
Release date

2019

Region

Worldwide

Survey time period

as of 2019

Supplementary notes

All figures are rounded; 2028 figures are projected. Percentage points exceeding 100 percent are probably due to rounding.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical market worldwide "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical market worldwide

Overview

6

Segments

6

Companies

8

R&D, patents, new products

7

Outlook

6

Review: COVID-19 response

6

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

CRISPR genome editingGlobal pharmaceutical industryBiotech drugsGenetically modified cropsAgriculture in the U.S.
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.